Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Servier, a Paris-based pharmaceutical company, has acquired the commercial, clinical, and research-stage oncology portfolio of Agios Pharmaceuticals, a Cambridge, Massachusetts-based pharmaceutical company, for up to $2 billion plus royalties....

Amgen has agreed to acquire Rodeo Therapeutics, a Seattle, Washington-based biopharmaceutical developing small-molecule therapies, in a $721-million deal ($55 million upfront and future contingent milestone payments potentially worth up to an...

The European Medicines Agency has approved facilities and/or facility expansions in the European Union for COVID-19 vaccines from Pfizer/BioNTech, Moderna, and AstraZeneca. Pfizer/BioNTech A new facility at BioNTech’s site in Marburg, Germany was...

As part of an ongoing divestment program of non-core assets following its $62-billion acquisition of Shire in 2019, Takeda Pharmaceutical has completed three divestments totaling approximately $4.1billion. $2.2-Bn Deal with Blackstone In the...

The European Commission (EC) has introduced new criteria in its export authorization mechanism for COVID-19 vaccines for destination countries receiving vaccines from the EU. The European Union’s (EU) transparency and authorization mechanism for...

The Board of Directors of the Drug, Chemical & Associated Technologies Association (DCAT) has decided to postpone the in-person portion of DCAT Week until March of 2022. A virtual version of DCAT Week 2021 will be offered from July 12-16th and...

Several countries in the European Union (EU) have temporarily suspended use of AstraZeneca’s COVID-19 vaccine due to a small number of incidences of blood clots forming in people who had received the COVID-19 vaccine while the European Medicines...